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NONSPECIFIC COMPLEMENT ACTIVATION BY 
STREPTOCOCCAL STRUCTURES 
II.  Properdin-Independent Initiation of the Alternate Pathway* 
BY J. W. TAUBER, M. J. POLLEY, AND J. B. ZABRISKIE 
(From The Rockefeller University and Cornell University Medical College, New York 10021) 
The  observation  (1)  that  inhibition  of HLA  cytotoxicity by  streptococcal 
antigens  was,  in  reality,  due  to  consumption of complement (C)  by  these 
antigens prompted us to further investigate the mechanism of  this consumption. 
Several possibilities for this anticomplementary  activity were considered. Since 
human sera often contain antibodies to a number of streptococcal antigens, a 
specific interaction between bacterial structures and their corresponding anti- 
bodies  was  conceivable. In general,  antigen-antibody complexes trigger the 
classical pathway, but there have been recent reports  (2) of activation of the 
alternate pathway by these complexes as well. The evidence against specific 
antibody as the main mechanism of C consumption was the observation that the 
preincubation of streptococcal membranes with rabbit C yielded the most signif- 
icant loss  of C  activity.  Although unlikely, the  possibility that  rabbit  sera 
contain antistreptococcal antibodies could not be completely excluded. 
Secondly,  while  we  suspected  that  streptococcal cellular structures  were 
responsible for the activation, one had to consider that other substances either 
exogenous or endogenous to the organism could be responsible for the effect. In 
the former category were agents such as endotoxin, known for its anticomple- 
mentary effect (3), the culture medium which contains yeast extract [perhaps 
related to  zymosan (4)], or enzymes (5)  used during the purification of the 
membranes (6). The endogenous source of contamination includes other cell 
constituents which might be present as contaminants of our membrane prepara- 
tion.  Among these possibilities  one must consider ribonucleotides which are 
known to bind Clq (7). Other isolated fractions from our laboratory, such as M 
protein from the cell wall and antigens cross-reactive with sarcolemma, were 
also tested for anticomplementary activity. 
Finally, the relative blocking efficiency  of Group A streptococcal membranes 
was always consistently greater than that observed with Group D membranes. 
Was this effect due to differences in the amount of anticomplementary sub- 
stance(s) present in each preparation, or were these discrepancies related to our 
assay system? In  addition,  was  this  anticomplementary activity present in 
gram-positive organisms other than Group A streptococci? 
With these questions in mind, a  number of experiments were designed to 
* This work was carried out in partial fulfillment for the requirements of a  Ph.D.  (J.  W. T.), 
supported by a  Rockefeller University fellowship and private funding. 
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test  each theoretical  possibility.  The present report  demonstrates that strepto- 
coccal structures clearly activate the alternate pathway of C  consumption. 
Neither antibody nor properdin is necessary for the activation  process and a 
direct  activation  of  factor  D occurred.  The particular  pathway is  clearly  different 
from the mechanisms  seen with other known activators  such as endotoxin, 
immune, or nonimmune  aggregates. The C activation  appears to occur with 
both cell  walls and membranes of  Group A streptococci  as well as with compo- 
nents of other gram-positive organisms. Using standard titration  of whole C 
hemolytic activity,  no significant  differences  between Group A  and Group D 
streptococci  could be found. 
Materials and Methods 
Bacterial Strains and Growth.  In addition to the originally used strains, S 43/192/2  and A932, 
[see (1)], the following streptococci were obtained from the collection of Dr. R. C. Lancefield, The 
Rockefeller University, New York. 
$43 GLOSSY.  This is a  Group A type 6 mutant strain which is an M-protein variant of the 843 
strain, originally isolated from a patient. 
Ass0.  Group A type 12 obtained from the throat of a patient in 1966. 
T12/126/6.  Group A type 12 obtained from the urine culture of a  patient in 1924. 
$23 BVR~ANK.  An M-protein mutant of a  Group A type 14 isolated from a patient with lobar 
pneumonia in 1918. 
C74.  Group C, not typed, from a human throat culture in 1941. 
DleeB.  Group  G,  not typed,  from a  skin lesion of a  child with epidermolysis bullosa,  1939, 
(Presbyterian Medical Center, New York). 
Dr. E. C. Gotschlich, The Rockefeller University, New York, kindly provided the following two 
gram-positive microorganisms: 
PNEUMOCOCCUS  CW-1.  Pneumococcus CW-1 is a mutant which does not produce pneumocoecal 
autolysing enzymes, thus permitting the isolation of its cell wall (8). 
BACmLUS PUMILIS SH-17.  Bacillus pumilis  SH-17 is a  mutant  strain which produces teichoic 
acid cross-reactive with Group A meningococcal polysaccharide  (9). 
The following bacteria were isolated from skin swabs: 
STAPHYLOCOCCUS  EPIDERMIDm.  Staphylococcus epidermidis is a strain which does not produce 
protein A and thus avoids the possibility of nonspecific binding of antibody (10). 
All these microorganisms were resusponded from lyophilized form. After several subcultures, 
the final harvest was carried out in 0.25-3.0 liters of medium (see reference 1). 
Isolation of Walls and Membranes.  All strains (except $43/192/2, see Table I) were identically 
treated by mechanical disruption with glass beads for 40-60 rain (11) until more than 90% of the 
organisms became gram negative. Differential centrifugation was followed by a  brief treatment 
with RNase, including a saline wash before resuspension in distilled H~O and lyophilization (1). 
Lipid Extraction and Fractionation.  500 mg lyophilized membranes of $43/192/2  were resus- 
pended in 10 ml Folch reagent (chloroform to methylalcohol, 2:1) (12) in the cold with continuous 
sonication in a water bath  (see reference 1) for 2 h. After paper filtration and vigorous shaking 
with 2 ml 0.04% CaC12 for 2 min, centrifugation for 10 rain at low speed resulted in the separation 
of two phases.  Thus, three fractions resulted from this procedure: 
Filter residue  =  mainly proteins 
Filtrate  1  Top phase (HsO)  = polar lipids 
Bottom phase (CHCIs) = nonpolar lipids 
The last  was further fractionated into  simple and composite lipids  by column (0.8 x  16 cm) 
chromatography with silicic  acid (Lipid  Chromatograph grade, -325 mesh; Sigma Chemical Co., 
St. Louis, Mo.) (12). 
The simple lipids,  eluted with 10 ml CHCIs, include fatty acid triglycerides,  glycerol,  and 
steroids.  The composite lipids,  eluted  with MetOH, mainly consist  of  phospholipids  clearly  visible 1354  PROPERDIN-INDEPENDENT INITIATION OF  ALTERNATE  PATHWAY 
initially as a yellow band 1 cm underneath the top of the column. The throe lipid fractions were 
blown to dryness under nitrogen and the filter residue was lyophilized. No attempt was made to 
further quantify the yield. Phospholipids make up approximately 50% of  the total lipids, the latter 
varying between 25-30% of the membranes (13). 
The residue remaining a/ter lipid extraction was treated in several different ways. A sample 
was treated with 3 M KC1 in acetate buffer, pH 5.0, for 48 h at room temperature, followed by high 
speed centrifugation at 100,000 g. The supernatant fluid was subjected to molecular-sieve  chroma- 
tography on a Sephadex G100 column equilibrated in acetate buffer, pH 5.0. A second sample was 
mixed with 1% Triton-X in 0.01 M Tris buffer, pH 8.3, and continuously sonicated overnight at 
45°C. This was followed by high speed centrifugation (see above) and ion-exchange chromatogra- 
phy using DEAE-cellulose  and a linear gradient from 0 to 3 M NaCI. A third sample was placed in 
5% Emulphogen (GAF Corp., New York)  in 0.01 M Tris buffer, pH 8.3, and sonicated overnight 
and centrifuged as outlined. The supernate was placed on an isoelectric-focusing column and run 
for 48 h, using a linear pH gradient from 5 to 8 in 50% sucrose. These pooled lyophilized fractions 
were stored at 4°C until further use. The protein patterns of these fractions were analyzed in 
sodium dodecyl sulfate polyacrylamide slab electrophoresis (9). 
Enzyme Studies.  Whole membranes from strain $43/192/2, as well as the residue after lipid 
extraction, were digested with 1 mg/ml trypsin (Worthington Biochemical Corp., Freehold, N. J.), 
180 U/rag in 0.046 M Tris, pH 8.1 with 0.0115 M CaCI2 and/or with 10 mg/ml phospholipase LP 5550 
from wheat germ (1.5 U/rag) (kindly supplied by Dr. M. W. Chase, The Rockefeller University, 
New York) in 0.15 M Na acetate, pH 5.0, for various periods of time at 37°C. The trypsin reaction 
was stopped by adding a twofold excess of Soybean trypsin inhibitor (ICN Nutritional Biochemical 
Div., International Chemical & Nuclear Corp., Cleveland, Ohio). This was followed by high speed 
centrifugation  at 150,000  g for  3 h. Both pellet  and supernate were tested  as indicated  below. 
C  Assays.  C  activation was determined subsequent to incubation with the various test 
fractions  for  i  h at  37°C,  measured by standard hemolytic titration  (CH50) and/or  direct  immuno- 
electrophoretic  determination of conversion of  factor  B to activated factor  B  (13)  ~  and C3 to C3i 
utilizing  specific  antisera (14).  In order to  differentiate  between the two different  pathways of  C 
activation,  1/10  volume of  the following buffers  were added to C before incubation: 
0.I M  ETHYLENEGLYCOL-BIS-(BETA-AMINO-ETHYL  ETHER) N,N'TETRA-ACETIC  ACID (EGTA).  EGTA 
(Sigma Chemical Co.)  with 0.05  M  MgCI2 in  normal saline,  pH 7.4,  known to  selectively  block  the 
classical  pathway by chelation of Ca  ++ (15);  the concentration used was shown to completely 
prevent hemolysis by the classical  pathway. 
0.1  M  (ETHYLENEDINITmLO)TETRA-ACETIC  ACID  (EDTA).  EDTA  (Eastman Organic Chemicals 
Div., Eastman Kodak Co.,  Rochester, N. Y.) in normal saline,  pH 7.4,  which by chelating both 
Ca  ++ and Mg  ÷+ blocked both pathways, the classical  and the alternate. 
NORMAL SALINE.  The residual C was calculated as the percentage of  the control incubated 
simultaneously  with the corresponding  buffer alone. The amount of C  consumed by the test 
substances was then achieved by subtracting the results  obtained from 100%. 
A  semiquantitative microassay of C  (18)  was modified as follows:  Doubling dilutions  of  test 
materials were incubated  with  equal  volumes of  diluted  C in  microculture plates  (catalogue  no. 13- 
7595-03;  Ace  Scientific  Supply Co.,  Inc.,  Linden, N. J.)  at  37°C  for  30  rain.  Sheep  red  cells  sensitized 
with rabbit  antisheep red  cell  antibody (EA) (17)  were added  to  the microplates and incubated  for 
an additional  60 rain.  The degree of  hemolysis of  EA obtained was a measure of  the  residual  C. 
C  Sources.  Whole human serum obtained from normal, healthy individuals was stored in 
aliquots  at -70°C until use.  For the study of  the alternate pathway, individual serum proteins 
were removed as follows: 
PROPERDIN.  Fresh human serum was incubated with 2 mg/ml zymosan (catalogue  no. Z-4250 
from  S. cerevisiae yeast;  Sigma Chemical Co.)  at 17°C for  I  h,  centrifuged in  the  cold  at  2,000g for 
30 min and the supernate stored at -70°C (18). 
FACTOR D.  2 ml of  frosh  human serum were subjected  to  molecular-sieve chromatography on a 
Sephadex G75 column (1.5  × 90 cm, equilibrated  with 0.15  M  NaCl and 0.002  M  EDTA, pH 7.3). 
The bulk of  the serum proteins  was eluted in  two peaks, pooled,  and concentrated to  the original 
volume with a PM10 Amicon filter  (Amicon Corp., Scientific  Sys.  Div.,  Lexington, Mass.) at 2- 
i  Abbreviations  used in this  paper: l~, activated factor  B; EA, sheep red cells  sensitized  with 
rabbit antisheep red cell  antibody; P, properdin; WHS, whole human serum. J.  W.  TAUBER,  M.  J.  POLLEY,  AND  J.  B.  ZABRISKIE  1355 
4°C. Factor D, because of its low molecular weight,  eluted later from the column  (19) and was 
discarded. 
FACTOR B.  Whole human serum was incubated at 50°C for 30 min (20). 
COMPONENT C3.  Whole human serum was incubated at 37°C for 60 min with 0.015 M hydrazine 
hydrate (21). 
COMPONENT C2.  Whole human serum from a patient homozygous for C2 deficiency (22) was 
kindly provided by Dr. S. M. Fu and Dr. H. G. Kunkel, both from The Rockefeller University, 
New York. 
IMMUNOGLOBULINS. Whole human serum from a patient with severe hypo-gammaglobuline° 
mia was kindly provided by Dr. T. Hoffman, The Rockefeller University, New York, and Dr. H. G. 
Kunkel. This serum was known to have normal C levels and the alternate pathway was shown to 
be intact.  IgA and IgM were not detectable while  IgG was 140 mg/ml (T. Hoffman,  personal 
communication). 
Endotoxin Assays.  The Limulus gelating test (23), as well as the chicken  embryo test (24), 
were carried out according to standard procedures. 
Biochemical assay. 
GLUCOSE.  Glucose was determined enzymatically utilizing Glucostat (Worthington Biochemi- 
cal Corp.) in the semimicro method. 
RHAMNOSE.  Rhamnose was determined as methyl pentose according to the methods of Dische 
and Shettles (25). 
Results 
Differentiation  between  Classical  and Alternate  Pathway  of C  Consump- 
tion.  Considering the possibility that human sera might contain antibodies to 
streptococcal antigens, C consumption experiments were first carried out in the 
presence  and  absence  of chelating  agents.  Fig.  1  shows that  EGTA  (hatched 
bars) completely fails to prevent C consumption in the presence of 0.5 mg/ml of 
streptococcal membranes.  This indicates  that the  C  activation was all accom- 
plished  via  the  alternate  pathway.  At  other  concentrations  of streptococcal 
membranes, however, there is a consistant difference between C consumption in 
the presence of EGTA (hatched bars) and the controls without chelating agents 
(white  bars).  This  small difference suggests that a  small amount of C  is con- 
sumed via the  classical pathway possibly due to the presence of specific anti- 
streptococcal antibody in  the human  sera used.  These observations were con- 
firmed on the same samples by a different assay system in which activation of C 
was measured indirectly by immunoelectrophoretic conversion of factor B  to I3 
(Fig.  2)  and  C3  to  C3i  (not  shown).  Both  these  factors  were  converted when 
whole serum was incubated with streptococcal membranes. This effect was only 
slightly diminished by the presence of EGTA. However, this difference (compare 
also Fig.  1), although small, perhaps indicates antibody-mediated activation of 
C via the classical pathway. EDTA completely inhibited consumption of C  (data 
not shown). 
Localization  of Bacterial Factors Responsible for the Effect.  In  the  same 
pilot study an attempt was made to determine on a weight basis which of the two 
major streptococcal cellular structures  (membranes or cell walls) contained the 
greatest  amount  of the  activating  substances.  Since  previous  work  (12)  has 
demonstrated  that  cell walls  are  usually contaminated  by membranes,  a  cell 
wall preparation was selected which contained the least amount ' of membrane 
contamination (Table I). Similarly the purest "wall-free" membrane preparation 
was selected for these experiments. As can be seen in Fig.  1, membranes at two 
different concentrations contained more of the material capable of consuming C 1356  PROPERDIN-INDEPENDENT  INITIATION  OF  ALTERNATE  PATHWAY 
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FIG.  1.  The difference in the percentage of C consumption by streptococcal plasma mem- 
branes and cell walls, respectively. The white bars refer to the percentage of C consumed in 
the absence of chelators. The hatched bars refer to consumption in the presence of  chelating 
agent EGTA, which permits activation of the alternate pathway only. 
FIG.  2.  The conversion of B to B. Native  B shows migration  to the anode (upper pair), 
while active 13 migrates to the cathode (lower pair). Activation was achieved with 0.4 mg/ml 
Group A streptococcal (Strep) membranes from $43/192/2. The strength of the precipitates 
can be estimated,  and thus quantitative information is available.  The lower wells of each 
pair show the conversion after incubation  with Mg/EGTA. The 10% remaining  native B 
(last well) correlates to the amount of C activated via classical pathway found by hemolytic 
titrations  (Fig. 1). 
via both (white bars), as well as via the alternate pathway only (hatched bars) 
than did wall preparations. 
Determination  of Essential  Serum  Factors.  Since  the  above  experiments 
indicated that the primary activation of C occurred via the alternate pathway, 
the next step taken was to attempt to determine at what point in the alternate 
pathway did this activation occur. For the sake of clarity, the major components 
of this  pathway  have  been  schematically  outlined  in  Fig.  3.  The  different J.  W.  TAUBER,  M.  J.  POLLEY,  AND  J.  B.  ZABRISKIE 
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The "Purest" Bacterial Preparations Used 
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Microorganism  Membranes  Cell Walls 
Contami- 
Rham-  nation 
Strain  Group  Type  nose  with  Dry weight  Glucose 
wall* 
Contami- 
nation 
with 
mem- 
brane* 
%  %  mg  %  % 
$43/192/2§  A  6  0.5  1.9  -  -  - 
T  12/126/6  A  12  -  -  300.011  0.3  14.3 
* On the basis  of  27% rhamnose in walls. 
* On the basis  of 1.9% glucose in membranes. 
§ This strain  was treated with lysin  to achieve the separation of  wall and membranes. 
II  Kindly provided by Geraldine Siviglia,  The Rockefeller  University, New York. 
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FIG. 3.  A schematic representation of  the  various components of  the  alternate  C pathway 
(for  synonyms see Table II). 
nomenclatures for each component of the system are given in Table H. For this 
purpose, the immunoelectrophoretic conversion system was used (14) with sera 
selectively deprived of particular C proteins. The results are given in Table III. 
As expected, whole human serum (WHS) exhibited almost total electrophoretic 
conversion of factor B to factor 13 and C3 to C3i.  C2-deficient serum  (C2)  gave 
essentially identical results to those obtained with WHS. Surprisingly, a similar 
degree of conversion was obtained in serum lacking properdin  (P) suggesting 
that the activation had occurred in the absence of P. No conversion was obtained 
in the serum lacking factor D, thus indicating that this factor was essential for 
the reaction. Removal of C3 also led to some reduction in degree of conversion of 
factor B. However, this may be due simply to the interruption of the "amplifica- 
tion loop" via C3b (26). Finally, serum lacking factor B activity failed to activate 
C3, an observation which thereby excluded a direct effect of the agents on C3 (5). 1358  PROPERDIN-INDEPENDENT  INITIATION  OF  ALTERNATE  PATHWAY 
TABLE  H 
Terminology of the Alternate Pathway 
Symbol  Synonyms  tool  wt 
IF 
P 
D 
B 
C3 
CoVF 
Initiating factor or nephritogenic factor (C3 NeF)  150,000 
Activated P  184,000 
Native factor  D  or  C3  proactivator convertase  (C3  PA  25,000 
convertase, C3 PAase GBGase) 
Activated factor I:)  235,000 
Native factor B or C3 proactivator (C3 PA) or glycin-rich  80,000 
beta glycoprotein (GBG) 
Active factor  I3  or  C3  activator  (C3  A)  or  glycin-rich  60,000 
gamma glycoprotein (GGG) 
Glycin-rich alpha glycoprotein (GAG)  20,000 
Third component or former factor A  180,000 
Cobra venom factor  140,000 
TABLE III 
Alternate Pathway Activation by Streptococcal Membrane or 
Inulin in Sera Deprived of Individual Factors 
Missing serum factor  C3"  B$ 
-  90§  80 
451l  20 
P  85  80 
10  5 
C3  -  25 
-  0 
D  0  0 
0  0 
B  0  5 
0  10 
*  % conversion  of  C3  to  C3i  after  subtraction  of  parallel  control,  utilizing 
saline  alone. 
$  % conversion  of  B to  I~  after  subtraction  of  parallel  control,  utilizing 
saline  alone. 
§  % conversion  after  incubation  with  0.2  mg/ml  membranes  from  strep- 
tococcus  A/6,  strain  $43/192/2  (top  line  in  each  pair  of  entries). 
II  % conversion  after  incubation  with 10 mg/ml inulin  (bottom  line  in 
each  pair  of  entries). 
To elucidate the difference in the point of  activation between streptococcal 
membranes  and the plant polysaccharide inulin (a known  activator  of the 
alternate pathway), both compounds were simultaneously tested. As shown in 
Table III,  in  the absence of  P, 10  mg/ml of  inulin  led  to only  minimal conversion 
of  factor  B, a degree comparable to  that  of  the  saline control.  In  contrast, 0.2  rag/ 
ml of  streptococcal membranes produced approximately 80% conversion  of  factor 
B. 
In an attempt to determine  what role, if any, antibody to streptococcal 
antigens played in  the conversion of  factor  B, a hypogammaglobulinemic serum J.  W.  TAUBER,  M.  J.  POLLEY,  AND  J.  B.  ZABRISKIE 
TABLE  IV 
Alternate Pathway Activation by 0.1 mg/ml Streptococcal 
Membranes in Hypogammaglobulinemic Serum* Deprived of P 
Serum reconstituted with:  C35  B$ 
-  50  35 
Antistreptococcal antibody§  55  45 
* All incubations carried out in the presence of Mg/EGTA, thus block- 
ing the classical pathway of C activation. 
* See Table III. 
§ Addition of 1/lO volume heat-inactivated serum of a rheumatic patient 
with a high titer of heart-reactive antibody. 
1359 
was used instead of the normal serum. Table IV demonstrates that this serum, 
even though deficient in immunoglobulins, showed approximately 35% conver- 
sion of factor B  to t]. Addition of a  serum known to contain antistreptococcal 
antibodies increased the conversion by only 10%. These results suggested that 
immunoglobulins play only a  minor role in the activation mechanism under 
investigation. 
Characterization  of C-Activating  Principles.  While  the  experiments  de- 
scribed in Fig. 1 indicated that streptococcal membranes contained more of the 
C-activating factor than did the cell walls,  it was not clear which particular 
portion of the membrane contained the active principle. Accordingly, the mem- 
brane preparation with the least amount of cell wall contamination (see Table I) 
was further divided into a lipid fraction and a protein residue, respectively. An 
undissociated membrane preparation obtained from the same batch of mem- 
branes served as a control. Fig. 4 demonstrates that the majority of  the anticom- 
plementary activity of streptococcal membranes resided in the protein residue 
portions  of the  membrane  ai~r  lipid  extraction.  While  the  composite  lipid 
portion  of the  membrane was  also  anticomplementary, the  use  of selective 
chelating agents indicated that  C  activation by the lipid  components of the 
streptococcal membrane was exclusively confined to the activation of C by the 
classical pathway. 
Further experiments revealed a number of biological characteristics of this C- 
activating factor. The material was heat sensitive and lost 75% of its activity 
after 2 h  incubation at 70°C. It was resistant to the action of both trypsin and 
phospholipase enzymes. The material contained little or no endotoxin as evi- 
denced by the lack of activity detected in the chicken embryo test, and less than 
0.04% contamination was noted in the Limulus test. Column chromatography of 
the solubilized fractions of the protein residue (see Lipid Extraction and Frac- 
tionation in the Materials and Methods) revealed that protein fractions less than 
60,000 daltons resulted in loss of activity. In addition, partially purified immu- 
nologically active  M  protein  (kindly provided  by  Dr.  V.  A.  Fischetti,  The 
Rockefeller University, New York) preparation (-40,000 daltons) and strepto- 
coccal antigens (kindly provided by Dr. I. van der Rijn, The Rockefeller Univer- 
sity, New York) cross-reactive with human sarcolemma (-30,000 daltons) failed 
to activate the C system. As a  final control, both the culture medium used to 
grow the streptococci as well as the phage lysin used for the isolation of the 1360  PROPERDIN-INDEPENDENT  INITIATION  OF  ALTERNATE  PATHWAY 
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FIG.  4.  Whole streptococcal membranes (membr) consume C via both alternate (hatched 
bar) as well as classical pathway (differences between hatched and white bar). The respon- 
sible factors for this dual mechanism could be neatly split by a  simple lipid extraction: 
activation of the alternate pathway was due entirely to the protein residue while activation 
of the classical pathway was all due to the complex lipids. 
streptococcal membranes were tested for their anticomplementary activity and 
were found to be nonreactive. 
C Consumption by Other Hemolytic Streptococci.  Since the majority of the 
experiments had been carried out with purified membranes obtained from a 
single Group A  streptococcal strain,  it was of interest to determine whether 
other hemolytic streptococci contained the active principle. For those purposes, 
mechanically disrupted streptococci were employed in order to achieve more 
uniform preparations of streptococcal cell walls and membranes. Also included 
in this series of experiments were strains from Groups C, D, and G streptococci. 
Tests were employed to measure consumption of hemolytic C and as in previous 
experiments each preparation was tested in the presence or absence of selective 
chelating agents in order to determine the relative degree of C activation by 
each pathway. As shown in Figs.  5 a  and 5 b,  the activating principle was 
present in  all  strains tested.  Both  cell walls and membranes contained the 
activating factor. By utilizing the chelating agents, it was possible to show that 
cell walls activated the classical pathway to a greater degree than did strepto- 
coccal membranes. This is perhaps not suprising in view of the many antigens 
present in streptococcal cell walls capable of inducing the formation of strepto- 
coccal antibodies in human sera (27). It must be emphasized however that the 
method of preparation of these structures makes it difficult to decide which 
fraction of the streptococcal cell contained the greatest amount of C activation. 
A perusal of Table V indicates that all cellular components tested contained 
significant amounts of mutal contamination of cell walls with membranes and 
vice versa. 
With  respect to  membrane preparations,  the  method of isolation  did  not 
appear  to  influence the  results.  Fig.  6  demonstrates that  the  degree of C 
consumption was the same irrespective of  whether membranes were prepared by 
lysis extraction or were mechanically disrupted. 
Consumption by Other Gram-Positive Organisms.  Experiments were de- 
signed to  determine whether gram-positive organisms other than hemolytic 
streptococci  were  capable  of activating  the  system.  Several  gram-positive 
strains were selected. In each case (see Fig. 7 a and 7 b) both cellular structures 
(membranes and walls)  were capable  of activating the  C  pathways.  In the J.  W.  TAUBER,  M.  J.  POLLEY,  AND  J.  B.  ZABRISKIE 
@  - 4ol  S're 'membranes'O'Oi  mg/m" 
0 
strain  $43 glossy  S23  C74  A932  DI66B 
group/type  A/6  A/14  C  O  G 
1361 
@ 
I0  i°°i ib 
~2o 
g 
Q.) 
o 
strain  $45 glossy  $23  C74  A932  Ot66B 
group/type  A/6  A/14  C  D  G 
FIG. 5.  (a) Anticomplementary  activity of membranes from various streptococcal  (Strep.) 
strains. (b) Anticomplementary  activity of cell wall preparations from various streptococcal 
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TABLE V 
Biochemical Composition of Mechanically Disrupted Streptococcal Strains 
Streptococcal  strains  Group 
Membranes  Cell  walls 
Contamina-  Contamina- 
Rhamnose  Glucose 
tion*  tion* 
%  %  %  % 
$43 Glossy (Type 6)  A  4.1  15.2  .41  20.4 
$23 Burbank (Type 14)  A  5.3  19.6  .52  26.0 
C74  C  4.1  15.2  .58  29.1 
D166B  G  5.9  21.9  .37  18.6 
* See Table I. 
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FIG. 6.  The anticomplementary activity  of mechanically prepared membranes as com- 
pared to lysin-extracted  material. No significant  difference  in C consumption was seen 
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nisms other than streptococci  (Strep.). (b) Anticomplementary activity of cell wall prepara- 
tions from various gram-positive microorganisms other than streptococci.  Staph., staphylo- 
COCCUS. 
presence of EGTA the differences in C consumption between strains as well as 
the differences between the various cellular components were minimal.  How- 
ever, it must be emphasized in these experiments that the methods used for the 
preparation  of pure  cell  walls  and  membranes  are  crude  and  only reflect  a 
general enrichment of the particular cellular components. 
Discussion 
Our finding that streptococcal antigens as well as constituents from certain 
other gram-positive microorganisms may activate the alternate C pathway at 
the particular level of factor D is rather unexpected. Due to the availability of 
the two deficient sera, one lacking C2 and the other hypogammaglobulinemic, it 
has been possible to confirm the initial indications that certain gram-positive 
microorganisms contain factors which can activate the alternate pathway by a 
mechanism not requiring immunoglobulins. Our studies further indicate that P 
is not required  for this  activation.  Although we know that  certain  cell wall 
constituents from gram-negative organisms such as endotoxin (3) also activate 
the alternate pathway, this mechanism is P dependent and thus differs from our 
findings. On the other hand, certain bacterial  enzymes act directly on C3  (5). 
That this is not the case in our experiments was clearly demonstrated by the 
observation that no conversion was seen with a  serum which was deficient in 
factor D. 
Our attempts to localize the active principles led to the conclusion that the 
necessary factors are certainly present in membrane preparations which were 
shown to be almost free of cell walls. Nevertheless, these factors also appear to 
be  present  in  cell  wall  fractions.  It  must be  emphasized  however that  our J.  W.  TAUBER,  M.  J.  POLLEY,  AND  J.  B.  ZABRISKIE  1363 
methods for isolating cell  walls are crude and all cell  wall preparations con- 
tained a significant  amount of  membrane  material. In addition, the conforma- 
tion of  these membranes may be important. For example, contaminating mem- 
branes are attached in a more rigid  flat  fashion in cell  Wall preparations, while 
they tend to fold  into  spheres when isolated as ruptured protoplasts (26).  This 
conformational  shape of the membranes  could hinder the exposure of their 
whole surface and thus explain different  quantitative results.  The sonication 
technique used before incubation of  the preparations with C is a rather mild 
procedure and may not dissociate  aggregated protoplast membranes. 
Studies of  the localization  of  the activity  within the membrane shows that  the 
active  principle  is  in  the residual material ai~r lipid  extraction.  Futher studies 
are planned to identify and isolate  the responsible moiety within the residue 
fraction. The active principle appears to be a high molecular weight fraction 
since, in preliminary experiments, all fractions  having a tool  wt below 40,000 
showed no consumption of  C. 
How do these findings fit  with the data reported by Hirata and Terasaki (29) 
and Rapaport et al. (30)  who did not find substantial anticomplementary activ- 
ity in their streptococcal extracts? With respect to the former authors, they 
stated that only M-protein preparations prepared from type 1 streptococci  were 
active while other M-protein extractions were noninhibitory. Since we did not 
use type 1 membranes,  it is conceivable  that the HL-A  cross-reactivity is 
specifically  related to a given M  protein from a particular strain.  However, the 
possibility  exists  that their preparations did in fact  exhibit an anticomplemen- 
tary effect  but the conditions of  their experiment precluded the detection of  the 
anticomplementary  effect.  For example, no inhibition of cytotoxicity was ob- 
served when the HLA  antiserum was concentrated enough to kill  80% of  the 
cells. This finding is similar to results obtained by us. Yet, if  the serum is 
diluted to a 1:16 concentration, the C  effect  is clearly seen (1).  As we have 
pointed out, both the dilution of the antiserum and the concentration  of the 
antigens, and the mixture of  the various components of  the cytotoxicity  assay 
system are crucial  for  detection of  the activation of  the alternate pathway of  C. 
The observation by Rapaport et  al.  that  low molecular weight trypsin digest  of 
membranes  (30)  is not anticomplementary  has been confirmed in our hands. 
However, their  preparation is  a soluble substance and therefore does  not strictly 
reflect  the experimental conditions in cytotoxicity  studies where one deals with 
solid-phase conditions due to the presence of cell surface membranes.  Their 
negative control (as well as ours) after  preincubation of  this  soluble material 
with C  alone, i.e.  omitting the solid phase provided by the later  addition of 
target cells,  remains therefore ambiguous. The anticomplementary  activity  of 
this  soluble digest in the presence of  a membrane surface, such as the lympho- 
cyte membrane,  cannot be excluded and remains a distinct  possibility. 
Finally, a word has to be said about the clinical  implications of  activation of 
the alternate pathway by streptococcal antigens. For example, in acute post- 
streptococcal glomerulonephritis C1, C4, and C2 components of C are depressed 
early in the disease, yet later,  there is a  selective depression of C3 while the 
early components return to normal.  One may speculate that the reason some 
individuals contract the disease or progress to a more chronic form of glomerulo- 1364  PROPERDIN-INDEPENDENT  INITIATION  OF  ALTERNATE  PATHWAY 
nephritis  (31) may be  related in part to  an aberration within the alternate 
pathway. Even stronger evidence  for this possibility may be found in some forms 
of chronic glomerulonephritis not directly related to acute streptococcal infec- 
tions (32). Here C3 components are characteristically lowered while C1, C4, and 
C2, the early components, remain normal. Since many organisms were found to 
be capable of activating the alternate pathway, it is conceivable that these forms 
of glomerulonephritis are also due to an anomaly in the alternate pathway. 
Quite apart from these practical viewpoints, our data may give some insights 
into the phylogeny  of C. From the work on the starfish, we have learned that the 
factors of the alternate pathway may very well be the ancestors of the C system. 
This species lacks immunoglobulins as well as the corresponding early C compo- 
nents such as C1, C4, and C2. However, an interesting protein could be isolated 
from the hemolymph of such species which resembles in its enzymatic activity 
factor B; beth lower vertebrates as well as invertebrates possess a lytic C system 
which can be activated independent of antibody, namely via a pathway initiated 
by cobra venom (33). This would suggest that parts of the C system are more 
primitive  than  the  immune system itself.  It  is  clear that  these  archaic  C 
functions may represent the alternate pathway. This would mean that a primi- 
tive defense system existed already before the elaborate equipment for specific 
identification of targets was present. Accordingly, activators of the alternate 
pathway, rather than being unique, should be widely spread compounds which 
are shared by a variety of different microbes (as for example lipid A in various 
endotoxins of numerous gram-negative microbes). Our findings that not only 
several streptococcal strains but different species of  other gram-positive bacteria 
also contain activating factor(s) are in agreement with the results from other 
laboratories (34, 35) and support the theory that the alternate pathway might 
have been designed as a broad, nonspecific defense system. The immune system 
came later to improve specific identification and efficient elimination of appro- 
priate targets. Thus, antibody actually completes and enhances the effects of C 
rather than vice versa. 
However, the questions remain: why did the factors of the alternate pathway 
persist up to the present day? Is it possible that the alternate pathway has to fill 
occasional loopholes of specific immunity? For example, certain groups of strep- 
tococci possess structures that closely resemble normal tissue antigens and thus 
present forbidden targets for specific immune reactions. In this situation, the 
body would have to rely on other defense mechanisms. In this context, the 
alternate pathway would gain an important meaning far beyond that of a simple 
evolutionary relic. Correspondingly, a specific defect in the alternate pathway 
system might represent a substantial handicap. It could, in the first place, lead 
to a protracted beleaguering of the host by corresponding pathogens. Secondly, 
after repeated challenges, the host's suppressive mechanisms which protect it 
from self-destruction might become exhausted and fail to  prevent the  final 
production of an autoantibody. These possibilities may have to be taken into 
consideration in a future analysis of streptococcal-related diseases. 
Summary 
Complement consumption by isolated membranes and walls from Group A 
streptococci and various other gram-positive microbes has been tested. These J.  W.  TAUBER,  M.  J.  POLLEY,  AND  J.  B.  ZABRISKIE  1365 
microbial structures were found to activate the alternate complement pathway. 
However, unlike endotoxin, inulin, or other plant polysaccharides, activation of 
complement by our material  was  found to bypass  properdin.  The  activating 
factor(s)  also  differs from cobra venom in its/their requirement for factor D. 
Preliminary experiments suggest this factor isolated from membranes to be a 
protein and to have a  mol wt greater than 40-60,000 daltons. Our studies have 
led  us  to  speculate  that  the  phylogenetic role  of the  alternate  complement 
pathway may be the primordial nonspecific defense system which has retained 
certain fundamental aspects up to the present time. 
Linda Metakis cheerfully assisted with continuous technical advice. 
Received for publication 3 February 1976. 
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